title: Are SK channels a logical target for treating ventricular arrhythmias? First, do no harm.
authors.affiliation: Cleveland Clinic Department of Molecular Cardiology, Cleveland, OH. Electronic address: vanwagd@ccf.org.
authors.forename: David R
authors.initials: DR
authors.lastname: Van Wagoner
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D051640:Small-Conductance Calcium-Activated Potassium Channels / Q000187:drug effects*; D017180:Tachycardia, Ventricular / Q000503:physiopathology*
chemical_list: D000889:Anti-Arrhythmia Agents; D051640:Small-Conductance Calcium-Activated Potassium Channels
references.citation: Circ Res. 2004 Apr 30;94(8):1083-90
references.pmid: 15016735
references.citation: N Engl J Med. 1989 Aug 10;321(6):406-12
references.pmid: 2473403
references.citation: Circ Res. 2011 Apr 15;108(8):971-9
references.pmid: 21350217
references.citation: Clin Exp Pharmacol Physiol. 2014 Jul;41(7):524-32
references.pmid: 25040398
references.citation: PLoS One. 2014;9(10):e108824
references.pmid: 25271970
references.citation: Heart Rhythm. 2015 May;12(5):1003-15
references.pmid: 25620048
references.citation: Trends Cardiovasc Med. 2015 Aug;25(6):508-14
references.pmid: 25743622